PG
GILD icon

Pendal Group’s Gilead Sciences GILD Stock Holding History

Pendal Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$3.5M Buy
40,770
+12,291
+43% +$973K 0.03% 178
2022
Q3 		$1.76M Sell
28,479
-55,486
-66% -$3.5M 0.02% 215
2022
Q2 		$5.19M Buy
83,965
+51,019
+155% +$3.16M 0.05% 139
2022
Q1 		$1.96M Buy
32,946
+27,965
+561% +$1.79M 0.02% 259
2021
Q4 		$362K Hold
4,981
– – ﹤0.01% 457
2021
Q3 		$348K Sell
4,981
-293
-6% -$20.6K ﹤0.01% 456
2021
Q2 		$363K Sell
5,274
-22,535
-81% -$1.5M ﹤0.01% 446
2021
Q1 		$1.8M Sell
27,809
-11,841
-30% -$764K 0.02% 235
2020
Q4 		$2.31M Sell
39,650
-14,712
-27% -$888K 0.02% 198
2020
Q3 		$3.44M Sell
54,362
-14,903
-22% -$1.03M 0.04% 125
2020
Q2 		$5.33M Sell
69,265
-2,411
-3% -$185K 0.07% 102
2020
Q1 		$5.36M Sell
71,676
-78,032
-52% -$5.39M 0.09% 82
2019
Q4 		$9.73M Buy
149,708
+44,469
+42% +$2.9M 0.13% 85
2019
Q3 		$6.67M Sell
105,239
-43,138
-29% -$2.82M 0.09% 105
2019
Q2 		$10M Sell
148,377
-14,126
-9% -$929K 0.14% 74
2019
Q1 		$10.6M Buy
162,503
+35,206
+28% +$2.34M 0.15% 83
2018
Q4 		$7.96M Sell
127,297
-23,713
-16% -$1.66M 0.13% 100
2018
Q3 		$11.7M Sell
151,010
-24,686
-14% -$1.86M 0.16% 81
2018
Q2 		$12.4M Hold
175,696
– – 0.16% 97
2018
Q1 		$13.2M Sell
175,696
-137,202
-44% -$10.9M 0.17% 81
2017
Q4 		$22.4M Sell
312,898
-104,608
-25% -$7.94M 0.29% 56
2017
Q3 		$34.1M Buy
417,506
+105,689
+34% +$8.08M 0.44% 46
2017
Q2 		$22.1M Buy
+311,817
New +$20.7M 0.32% 65

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pendal Group's GILD Position: Q4 2022 in Review

Pendal Group increased its Gilead Sciences (GILD) stake by 43% in Q4 2022, buying an estimated $973K and bringing the position to 40,770 shares worth $3.5M. The position accounts for 0.03% of the portfolio, ranked #178.

Pendal Group first reported a position in GILD in Q2 2017 and has held it in 23 quarters since. The position peaked at $34.1M in Q3 2017. 1,768 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Pendal Group held 40,770 shares of Gilead Sciences worth $3.5M as of Q4 2022.
  • Pendal Group bought 12,291 Gilead Sciences shares in Q4 2022, an estimated $973K.
  • Gilead Sciences made up 0.03% of Pendal Group's portfolio in Q4 2022, its #178 holding.
  • Pendal Group first reported a position in Gilead Sciences in Q2 2017 and has held it in 23 quarters since.
  • Pendal Group's Gilead Sciences position peaked at $34.1M in Q3 2017.
  • 1,768 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.